Acute Treatment During the Aura Phase of Migraine
Do not routinely treat the aura phase itself with acute migraine medications; instead, wait until headache onset and then treat immediately with combination therapy (triptan plus NSAID or acetaminophen) for optimal efficacy. 1
The Evidence Against Treating During Aura
The most recent high-quality guidelines from the American College of Physicians (2025) explicitly recommend that patients "begin treatment of migraine headache as soon as possible after its onset" rather than during the aura phase 1. This recommendation is based on the understanding that:
- Triptans are ineffective when given during aura alone - The traditional teaching that triptan therapy during the visual aura phase is ineffective has been the standard for decades 2
- The guidelines focus on treating "acute, episodic, moderate to severe migraine headache" with medications designed to abort the headache phase, not the aura itself 1
The Nuance: Conflicting Research Evidence
There is one notable contradictory study that challenges this paradigm. A 2009 open-label crossover study found that sumatriptan 100mg given during aura preempted headache development in 89% of attacks (34/38 attacks) 3. However, this study has significant limitations:
- Open-label design (no blinding)
- Small sample size (19 subjects)
- The authors themselves acknowledged the need for "larger-scale, 3-way, crossover, placebo-controlled studies" to confirm these findings 3
- This evidence has not been incorporated into major clinical guidelines, suggesting the medical community views it as insufficient to change practice
Alternative Approach: Single-Pulse Transcranial Magnetic Stimulation
For patients specifically seeking to abort attacks during the aura phase, single-pulse transcranial magnetic stimulation (sTMS) is the only evidence-based intervention with proven efficacy during aura 4. A 2010 randomized, double-blind, sham-controlled trial demonstrated:
- 39% pain-free response at 2 hours (vs 22% with sham, p=0.0179)
- Sustained pain-free response at 24 and 48 hours
- No device-related serious adverse events 4
This device has evidence specifically for "acute treatment of migraine with aura" and works by treating during the aura phase itself 4, 2. However, access to this technology is limited in most clinical settings.
Practical Clinical Algorithm
Step 1: Educate patients that aura itself does not require treatment - it is self-limited and typically resolves within 60 minutes
Step 2: Instruct patients to treat immediately at headache onset (not during aura) with:
- First-line: Triptan + NSAID (or triptan + acetaminophen if NSAIDs contraindicated) 1
- This combination approach maximizes efficacy when given early in the headache phase
Step 3: For patients with severe nausea/vomiting during attacks, consider non-oral triptan formulations plus antiemetics 1
Step 4: If standard acute treatments fail, escalate to:
- CGRP antagonists (gepants: rimegepant, ubrogepant, zavegepant) 1
- Lasmiditan (ditan class) as last-line option 1
Critical Pitfalls to Avoid
- Do not use opioids or butalbital for acute migraine treatment 1
- Warn about medication overuse headache: ≥10 days/month with triptans or ≥15 days/month with NSAIDs can cause rebound headaches 1
- Do not delay treatment waiting for headache to worsen - early treatment at onset is more effective 1
- Traditional contraindications for triptans in hemiplegic migraine and migraine with brainstem aura are being reconsidered, though caution remains warranted 2
When to Consider Preventive Therapy
If migraines with aura occur frequently or acute treatment provides inadequate response, preventive medications should be added rather than attempting to treat the aura phase itself 1.